Stock listing
NASDAQ:PCVX Vaxcyte, Inc. Stock
Home listing (NASDAQ) of Vaxcyte, Inc.
Follow Vaxcyte, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:PCVX
$58.52 USD -0.88 (-1.5%)
Close on Nov 18, 2026
- Day range
- $57.60 – $59.69 USDNov 18, 2026
- Volume
- 1.13M sharesNov 18, 2026
- Market cap
- $9.26B USDAt the close on Nov 18, 2026 · price × 158.3M shares outstanding
- 52-week range
- $42.40 – $90.75 USDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
- Traded on an average day
- $137.1M USDMedian day 1.50M shares · last 3 months, Aug 18, 2026 – Nov 18, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PCVX · Home | $58.52 USD | -0.88 (-1.5%) | 1,128,702 | $59.16 | $59.69 | $57.60 | $59.40 | Close on Nov 18, 2026 |
| Frankfurt:5VA | €53.00 EUR | -1.00 (-1.9%) | 78 | €53.00 | €53.00 | €53.00 | €54.00 | Close on Nov 17, 2026 |
Daily closes
Last 3 months, Aug 18, 2026 – Nov 18, 2026 · NASDAQ:PCVX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $58.52 | -0.88 | -1.5% | $59.16 | $59.69 | $57.60 | 1,128,702 | |
| $59.40 | -2.21 | -3.6% | $61.88 | $62.59 | $59.07 | 1,107,693 | |
| $61.61 | -1.76 | -2.8% | $63.37 | $63.79 | $61.47 | 707,760 | |
| $63.37 | -1.32 | -2.0% | $64.64 | $64.64 | $62.84 | 623,288 | |
| $64.69 | -3.93 | -5.7% | $67.60 | $67.60 | $64.62 | 1,072,433 | |
| $68.62 | +2.26 | +3.4% | $66.99 | $68.92 | $66.56 | 1,622,014 | |
| $66.36 | -1.17 | -1.7% | $67.00 | $68.18 | $65.85 | 1,268,826 | |
| $67.53 | +3.64 | +5.7% | $64.75 | $67.62 | $63.93 | 1,252,192 | |
| $63.89 | +1.97 | +3.2% | $61.92 | $65.26 | $61.14 | 1,840,628 | |
| $61.92 | -3.76 | -5.7% | $65.88 | $65.88 | $61.84 | 1,833,645 | |
| $65.68 | +4.87 | +8.0% | $62.87 | $65.71 | $60.04 | 2,240,914 | |
| $60.81 | +0.19 | +0.3% | $61.38 | $61.89 | $60.32 | 2,159,747 | |
| $60.62 | -1.41 | -2.3% | $61.88 | $62.87 | $60.15 | 1,320,430 | |
| $62.03 | -0.58 | -0.9% | $62.59 | $63.28 | $61.02 | 1,714,259 | |
| $62.61 | +1.15 | +1.9% | $61.88 | $63.14 | $61.64 | 2,013,761 | |
| $61.46 | +0.79 | +1.3% | $59.92 | $63.94 | $59.58 | 2,212,599 | |
| $60.67 | +0.70 | +1.2% | $59.93 | $61.22 | $59.43 | 2,587,378 | |
| $59.97 | -0.46 | -0.8% | $60.68 | $61.50 | $59.19 | 1,469,410 | |
| $60.43 | -2.42 | -3.9% | $62.35 | $62.77 | $60.27 | 2,062,400 | |
| $62.85 | -0.38 | -0.6% | $62.96 | $64.58 | $61.56 | 2,771,300 | |
| $63.23 | -3.00 | -4.5% | $66.02 | $67.47 | $63.09 | 3,272,200 | |
| $66.23 | +2.55 | +4.0% | $63.80 | $67.01 | $63.68 | 1,956,700 | |
| $63.68 | +0.06 | +0.1% | $64.14 | $66.02 | $63.38 | 2,549,200 | |
| $63.62 | -1.65 | -2.5% | $65.13 | $65.34 | $62.54 | 3,249,900 | |
| $65.27 | -2.28 | -3.4% | $67.72 | $68.33 | $65.00 | 2,448,500 | |
| $67.55 | +0.75 | +1.1% | $67.07 | $69.21 | $66.00 | 1,525,200 | |
| $66.80 | -3.85 | -5.4% | $70.58 | $71.09 | $66.63 | 2,644,900 | |
| $70.65 | -0.73 | -1.0% | $71.08 | $72.89 | $68.97 | 2,427,600 | |
| $71.38 | +6.365 | +9.8% | $64.78 | $72.44 | $64.78 | 4,381,400 | |
| $65.02 | -1.945 | -2.9% | $67.14 | $67.97 | $63.79 | 3,848,100 | |
| $66.96 | +0.26 | +0.4% | $65.86 | $67.15 | $64.27 | 11,561,100 | |
| $66.70 | -7.12 | -9.6% | $73.35 | $73.40 | $63.90 | 10,156,100 | |
| $73.82 | +17.34 | +30.7% | $87.21 | $90.75 | $71.60 | 14,924,000 | |
| $56.48 | +0.43 | +0.8% | $56.76 | $57.00 | $55.84 | 2,399,600 | |
| $56.05 | -0.85 | -1.5% | $56.73 | $57.17 | $56.00 | 1,166,200 | |
| $56.90 | +0.21 | +0.4% | $56.69 | $57.51 | $56.13 | 1,508,700 | |
| $56.69 | -1.58 | -2.7% | $57.96 | $58.98 | $55.91 | 1,493,500 | |
| $58.27 | +2.06 | +3.7% | $56.50 | $58.82 | $55.75 | 1,849,000 | |
| $56.21 | -0.69 | -1.2% | $57.22 | $57.50 | $55.92 | 947,300 | |
| $56.90 | +0.405 | +0.7% | $55.86 | $57.59 | $55.09 | 1,852,000 | |
| $56.50 | -2.525 | -4.3% | $59.02 | $59.10 | $55.09 | 1,650,400 | |
| $59.02 | +0.10 | +0.2% | $59.45 | $59.96 | $58.78 | 1,282,700 | |
| $58.92 | +0.79 | +1.4% | $59.00 | $60.54 | $57.62 | 1,124,400 | |
| $58.13 | -2.24 | -3.7% | $60.37 | $60.37 | $57.01 | 2,717,400 | |
| $60.37 | +1.60 | +2.7% | $60.22 | $61.50 | $59.31 | 1,309,200 | |
| $58.77 | -0.44 | -0.7% | $59.25 | $60.13 | $58.40 | 1,249,200 | |
| $59.21 | -0.33 | -0.6% | $59.70 | $59.75 | $58.19 | 1,887,900 | |
| $59.54 | +0.07 | +0.1% | $60.04 | $60.86 | $59.09 | 1,428,400 | |
| $59.47 | +0.57 | +1.0% | $60.07 | $60.20 | $58.21 | 1,683,400 | |
| $58.90 | -0.61 | -1.0% | $59.19 | $60.13 | $58.56 | 1,160,700 | |
| $59.51 | -0.85 | -1.4% | $59.99 | $60.33 | $59.05 | 1,195,200 | |
| $60.36 | -0.80 | -1.3% | $60.25 | $61.03 | $59.22 | 1,024,400 | |
| $61.16 | -0.01 | 0.0% | $59.73 | $61.78 | $59.65 | 986,700 | |
| $61.17 | -0.41 | -0.7% | $61.73 | $62.14 | $59.85 | 736,500 | |
| $61.58 | +0.77 | +1.3% | $61.63 | $62.90 | $60.82 | 1,021,300 | |
| $60.81 | +0.07 | +0.1% | $60.29 | $62.14 | $60.06 | 1,441,100 | |
| $60.74 | +0.905 | +1.5% | $59.10 | $61.61 | $58.51 | 1,749,000 | |
| $59.84 | -1.32 | -2.2% | $61.06 | $62.38 | $59.49 | 759,700 | |
| $61.16 | +0.065 | +0.1% | $60.51 | $61.60 | $59.93 | 611,600 | |
| $61.09 | 0.00 | 0.0% | $61.04 | $61.65 | $60.32 | 891,600 | |
| $61.09 | -0.78 | -1.3% | $62.22 | $63.92 | $60.96 | 1,217,884 | |
| $61.87 | -0.75 | -1.2% | $62.30 | $63.05 | $61.23 | 662,140 | |
| $62.62 | +1.28 | +2.1% | $61.60 | $63.98 | $61.60 | 1,141,500 | |
| $61.34 | -1.96 | -3.1% | $62.23 | $62.91 | $60.80 | 726,100 | |
| $63.30 | +3.51 | +5.9% | $61.56 | $63.83 | $60.95 | 1,444,900 | |
| $59.79 | -0.43 | -0.7% | $59.97 | $60.86 | $59.50 | 705,900 |
- Ticker
- NASDAQ:PCVX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 4, 2026
Vaxcyte Reports Third Quarter 2026 Financial Results and Provides Business Update
Latest earnings call · Feb 24, 2026
Vaxcyte (NASDAQ:PCVX) Q4 2025 Earnings Call
Replay and transcript
Latest deck · Oct 5, 2026
Technical Presentation (October 2026)
Technical · 34 slides
Calls
Upcoming
Vaxcyte (NASDAQ:PCVX) Q3 2026 Earnings Call
Tue, Dec 01, 2026 · 9:35 AM ET
Register
Replays
Vaxcyte (NASDAQ:PCVX) Q4 2025 Earnings Call
Tue, Feb 24, 2026 · 4:30 PM ET
Watch TranscriptVaxcyte (NASDAQ:PCVX) Q4 2024 Earnings Call
Tue, Feb 25, 2025 · 1:30 PM ET
Watch TranscriptVaxcyte (NASDAQ:PCVX) Q4 2023 Earnings Call
Tue, Feb 27, 2024 · 4:30 PM ET
Watch Transcript
Latest news
Vaxcyte Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov 4, 2026
Closed $61.92 (-5.7%) on Nov 5, 2026
Vaxcyte Announces Closing of $1.15 Billion Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes, Including Full Exercise of Underwriters’ Options to Purchase Additional Shares and Convertible Senior Notes
Oct 9, 2026
Closed $70.65 (-1.0%) on Oct 12, 2026
Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes
Oct 6, 2026
Closed $66.96 (+0.4%) on Oct 7, 2026
Vaxcyte Reports Positive Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate Vaccine Candidate
Oct 5, 2026
Closed $73.82 (+30.7%) on Oct 5, 2026
Vaxcyte Appoints Chief Medical Officer and Chief Legal Officer; Narrows Guidance for Expected VAX-31 OPUS-1 Topline Data
Sep 3, 2026
Closed $61.16 (0.0%) on Sep 4, 2026
Vaxcyte Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 5, 2026
Closed $58.89 (+5.3%) on Aug 6, 2026
Vaxcyte to Participate in Upcoming Investor Conferences
Jul 8, 2026
Closed $59.83 (+1.9%) on Jul 9, 2026
Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults
Jun 2, 2026
Closed $46.93 (-1.0%) on Jun 3, 2026
Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update
May 6, 2026
Closed $51.48 (-9.8%) on May 7, 2026
Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference
Apr 7, 2026
Closed $60.69 (+1.5%) on Apr 7, 2026
Financings
Public offering of common stock and pre-funded warrants
Oct 9, 2026
Closed: US$500M raised · US$64 a share · Jefferies +7
Dealers: Jefferies (co-lead), Leerink Partners (co-lead), BofA Securities (co-lead), Evercore ISI (co-lead), Goldman Sachs & Co. LLC (co-lead), Guggenheim Securities (co-lead), Mizuho, BTIG
Use of proceeds: VAX-31 adult and pediatric clinical development, manufacturing scale-up, US launch preparation, early pipeline R&D and general corporate purposes
Announced Oct 5, 2026 · Update Oct 7, 2026 · Closed Oct 9, 2026
1.50% convertible senior notes due 2032
Oct 9, 2026
Closed: US$575M raised · Jefferies +8
Dealers: Jefferies (co-lead), Leerink Partners (co-lead), BofA Securities (co-lead), Goldman Sachs & Co. LLC (co-lead), Evercore ISI (co-lead), Guggenheim Securities, Mizuho, Needham & Company, J. Wood Capital Advisors
Use of proceeds: VAX-31 adult and pediatric clinical development, manufacturing scale-up, US launch preparation, early pipeline R&D and general corporate purposes
Announced Oct 5, 2026 · Update Oct 7, 2026 · Closed Oct 9, 2026
Public offering of common stock
Feb 2, 2026
Closed: US$632.5M raised · US$50 a share · BofA Securities +7
Dealers: BofA Securities (co-lead), Jefferies (co-lead), Leerink Partners (co-lead), Evercore ISI (co-lead), Guggenheim Securities (co-lead), Mizuho, BTIG, Needham & Company
Announced Jan 29, 2026 · Announced Jan 30, 2026 · Closed Feb 2, 2026
Decks
Technical Presentation (October 2026)
Technical · 34 slides · Oct 5, 2026
Technical Presentation (October 2026)
Technical · 35 slides · Oct 5, 2026
Investor Presentation (September 2026)
Investor deck · 80 slides · Sep 3, 2026
Q4 2025 Earnings Presentation
Earnings · 68 slides · Feb 24, 2026
Vaxcyte, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 25 in the last 12 months · 129 in all · newest Nov 4, 2026 · oldest 2020
- Calls
- 5 calls with a replay · 5 with a transcript · latest Feb 24, 2026
- Decks
- 9 decks · latest Oct 5, 2026
Where Vaxcyte, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PCVX · Home listing · This page | NASDAQ | United States | USD |
| gettex:5VA | gettex | Germany | EUR |
| LS Exchange:A2P6R6 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2P6R6 | Lang & Schwarz | Germany | EUR |
| Milan:1PCVX | Milan | Italy | EUR |
| BOATS:PCVX | BOATS | United States | USD |
| Frankfurt:5VA | Frankfurt | Germany | EUR |
| BX Swiss:PCVX | BX Swiss | Switzerland | CHF |
| Dusseldorf:5VA | Dusseldorf | Germany | EUR |
| Hamburg:5VA | Hamburg | Germany | EUR |
| Munich:5VA | Munich | Germany | EUR |
| Stuttgart:5VA | Stuttgart | Germany | EUR |
| Tradegate:5VA | Tradegate | Germany | EUR |
| Hanover:5VA | Hanover | Germany | EUR |
| Xetra:5VA | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Vaxcyte, Inc.